Susquehanna International Group
TNXP icon

Susquehanna International Group’s Tonix Pharmaceuticals TNXP Stock Holding History

Susquehanna International Group’s Portfolio TNXP Stock Details TNXP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.86M Buy
146,100
+71,000
+95% +$916K ﹤0.01% 6637
2026
Q1 		$1.03M Buy
75,100
+39,800
+113% +$613K ﹤0.01% 7810
2025
Q4 		$551K Buy
35,300
+21,100
+149% +$389K ﹤0.01% 8543
2025
Q3 		$343K Buy
+14,200
New +$527K ﹤0.01% 9805
2017
Q2 		– Hold
0
– -$62K – 9848
2017
Q1 		– Hold
0
– – – 8544
2016
Q3 		– Hold
0
– -$25K – 9058
2016
Q2 		– Hold
0
– – – 8356
2016
Q1 		– Hold
0
– -$607K – 9673
2015
Q4 		– Hold
0
– – – 6397
2015
Q3 		– Hold
0
– – – 8725
2015
Q2 		– Hold
0
– – – 9445
2014
Q4 		– Hold
0
– -$271K – 10103
2014
Q3 		– Hold
0
– – – 8176

Other funds holding TNXP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
JHC
Jones Hill Capital New York $470M AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
II
Ishara Investments Los Angeles, California $136M AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Susquehanna International Group's TNXP Position: Q2 2026 in Review

Susquehanna International Group increased its Tonix Pharmaceuticals (TNXP) stake by 45% in Q2 2026, buying an estimated $174K and bringing the position to 43,034 shares worth $549K. The position accounts for ﹤0.01% of the portfolio, ranked #9695.

Susquehanna International Group first reported a position in TNXP in Q1 2021 and has held it in 6 quarters since. The position peaked at $1.01M in Q1 2021. 102 funds tracked by Wall St. Rank hold TNXP as of Q2 2026.

  • Susquehanna International Group held 43,034 shares of Tonix Pharmaceuticals worth $549K as of Q2 2026.
  • Susquehanna International Group bought 13,455 Tonix Pharmaceuticals shares in Q2 2026, an estimated $174K.
  • Tonix Pharmaceuticals made up ﹤0.01% of Susquehanna International Group's portfolio in Q2 2026, its #9695 holding.
  • Susquehanna International Group first reported a position in Tonix Pharmaceuticals in Q1 2021 and has held it in 6 quarters since.
  • Susquehanna International Group's Tonix Pharmaceuticals position peaked at $1.01M in Q1 2021.
  • 102 funds tracked by Wall St. Rank held Tonix Pharmaceuticals as of Q2 2026.

Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.